Axonics Past Earnings Performance
Past criteria checks 0/6
Axonics has been growing earnings at an average annual rate of 21.7%, while the Medical Equipment industry saw earnings growing at 11.5% annually. Revenues have been growing at an average rate of 44.7% per year.
Key information
21.7%
Earnings growth rate
34.0%
EPS growth rate
Medical Equipment Industry Growth | 8.9% |
Revenue growth rate | 44.7% |
Return on equity | -0.3% |
Net Margin | -0.4% |
Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Recent updates
A Look At The Fair Value Of Axonics, Inc. (NASDAQ:AXNX)
Jul 14Axonics, Inc.'s (NASDAQ:AXNX) Earnings Haven't Escaped The Attention Of Investors
Jun 20Is Axonics, Inc. (NASDAQ:AXNX) Trading At A 21% Discount?
Mar 27Here's Why We're Not At All Concerned With Axonics' (NASDAQ:AXNX) Cash Burn Situation
Feb 28Is Axonics, Inc. (NASDAQ:AXNX) Trading At A 32% Discount?
Nov 28Axonics stock falls 5.6% after Needham downgrades rating
Oct 10Axonics Stock Is A Buy Amid Current Capex Cycle
Sep 07Axonics prices stock offering of 1.75M shares
Aug 03Companies Like Axonics (NASDAQ:AXNX) Can Afford To Invest In Growth
Aug 02Axonics: A Strong Medical Device Play With Significant Revenue Growth Opportunities
May 30Axonics (NASDAQ:AXNX) Is In A Strong Position To Grow Its Business
Apr 19We're Hopeful That Axonics (NASDAQ:AXNX) Will Use Its Cash Wisely
Sep 15Revenue & Expenses Breakdown
How Axonics makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Jun 24 | 409 | -2 | 265 | 42 |
31 Mar 24 | 387 | -16 | 252 | 38 |
31 Dec 23 | 366 | -6 | 235 | 35 |
30 Sep 23 | 343 | -12 | 223 | 33 |
30 Jun 23 | 320 | -32 | 213 | 33 |
31 Mar 23 | 296 | -46 | 208 | 31 |
31 Dec 22 | 274 | -60 | 196 | 34 |
30 Sep 22 | 241 | -76 | 181 | 36 |
30 Jun 22 | 217 | -77 | 168 | 37 |
31 Mar 22 | 194 | -80 | 151 | 39 |
31 Dec 21 | 180 | -80 | 136 | 37 |
30 Sep 21 | 162 | -76 | 121 | 35 |
30 Jun 21 | 150 | -68 | 109 | 34 |
31 Mar 21 | 120 | -63 | 95 | 32 |
31 Dec 20 | 112 | -55 | 92 | 29 |
30 Sep 20 | 87 | -66 | 89 | 27 |
30 Jun 20 | 53 | -82 | 87 | 24 |
31 Mar 20 | 39 | -81 | 82 | 23 |
31 Dec 19 | 14 | -80 | 68 | 20 |
30 Sep 19 | 4 | -67 | 51 | 19 |
30 Jun 19 | 3 | -49 | 34 | 18 |
31 Mar 19 | 2 | -39 | 21 | 19 |
31 Dec 18 | 1 | -32 | 13 | 19 |
30 Sep 18 | 0 | -28 | 10 | 18 |
30 Jun 18 | 0 | -25 | 7 | 17 |
31 Mar 18 | 0 | -20 | 6 | 14 |
31 Dec 17 | 0 | -18 | 6 | 12 |
Quality Earnings: AXNX is currently unprofitable.
Growing Profit Margin: AXNX is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: AXNX is unprofitable, but has reduced losses over the past 5 years at a rate of 21.7% per year.
Accelerating Growth: Unable to compare AXNX's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: AXNX is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (7.5%).
Return on Equity
High ROE: AXNX has a negative Return on Equity (-0.27%), as it is currently unprofitable.